Phase II trial of dichloromethotrexate in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study

Cancer Treat Rep. 1987 Dec;71(12):1295-6.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Squamous Cell / drug therapy*
  • Female
  • Folic Acid Antagonists / adverse effects
  • Folic Acid Antagonists / therapeutic use
  • Humans
  • Methotrexate / adverse effects
  • Methotrexate / analogs & derivatives*
  • Methotrexate / therapeutic use
  • Uterine Cervical Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Folic Acid Antagonists
  • 3',5'-dichloromethotrexate
  • Methotrexate